Share Price and Basic Stock Data
Last Updated: March 3, 2026, 2:21 pm
| PEG Ratio | 3.98 |
|---|
📊 Last updated
6d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Goodricke Group Ltd operates in the Plantations sector, specifically focusing on tea and coffee. The company’s stock price stood at ₹152 with a market capitalization of ₹328 Cr. Over the recent quarters, Goodricke’s revenue has shown fluctuations, with sales reported at ₹280 Cr in September 2022, peaking at ₹316 Cr in September 2024, before declining to ₹284 Cr in December 2024. The trailing twelve months (TTM) sales recorded ₹807 Cr, reflecting a slight dip from the previous year’s ₹882 Cr. The volatility in quarterly sales, particularly the drop to ₹100 Cr in March 2023, indicates challenges in maintaining consistent revenue flow. The company’s operational performance, characterized by a low operating profit margin (OPM) of 15% and a high price-to-earnings (P/E) ratio of 113, suggests that while revenue generation is present, profitability remains a concern. Overall, the fluctuating sales figures highlight Goodricke’s struggle to achieve stable growth within the competitive tea and coffee market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 326 Cr. | 151 | 240/149 | 112 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| United Nilgiri Tea Estates Company Ltd (UNITEDTEA) | 249 Cr. | 499 | 589/350 | 11.3 | 465 | 0.60 % | 10.1 % | 8.70 % | 10.0 |
| Mcleod Russel India Ltd | 412 Cr. | 39.4 | 68.7/27.6 | 6.08 | 0.00 % | 1.85 % | 142 % | 5.00 | |
| Peria Karamalai Tea & Produce Company Ltd (PKTEA) | 237 Cr. | 765 | 1,014/565 | 282 | 618 | 0.13 % | 1.50 % | 0.45 % | 10.0 |
| Gillanders Arbuthnot & Company Ltd | 189 Cr. | 88.7 | 152/85.0 | 12.2 | 120 | 0.00 % | 6.80 % | 6.83 % | 10.0 |
| Industry Average | 8,601.65 Cr | 385.22 | 52.18 | 265.00 | 0.45% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 306.53 | 100.28 | 165.71 | 241.46 | 286.56 | 130.25 | 197.44 | 315.94 | 284.22 | 131.84 | 174.51 | 216.56 | 306.37 |
| Expenses | 303.15 | 158.01 | 163.11 | 202.72 | 305.55 | 197.70 | 181.20 | 250.35 | 296.83 | 181.83 | 171.60 | 183.78 | 298.16 |
| Operating Profit | 3.38 | -57.73 | 2.60 | 38.74 | -18.99 | -67.45 | 16.24 | 65.59 | -12.61 | -49.99 | 2.91 | 32.78 | 8.21 |
| OPM % | 1.10% | -57.57% | 1.57% | 16.04% | -6.63% | -51.79% | 8.23% | 20.76% | -4.44% | -37.92% | 1.67% | 15.14% | 2.68% |
| Other Income | 3.76 | 5.38 | 1.83 | 2.32 | 2.48 | 3.64 | 2.33 | 3.14 | 3.46 | 15.90 | 5.38 | 13.96 | 5.60 |
| Interest | 2.11 | 0.66 | 1.92 | 2.52 | 3.11 | 2.56 | 3.18 | 2.95 | 2.50 | 1.54 | 2.19 | 2.01 | 1.70 |
| Depreciation | 5.34 | 4.78 | 5.26 | 5.15 | 5.18 | 5.09 | 5.18 | 5.11 | 4.95 | 4.60 | 4.60 | 4.63 | 4.52 |
| Profit before tax | -0.31 | -57.79 | -2.75 | 33.39 | -24.80 | -71.46 | 10.21 | 60.67 | -16.60 | -40.23 | 1.50 | 40.10 | 7.59 |
| Tax % | -25.81% | -21.60% | -35.64% | 0.15% | 0.97% | 6.12% | -22.33% | 0.66% | -2.83% | -9.10% | -112.67% | -8.55% | -5.93% |
| Net Profit | -0.23 | -45.31 | -1.77 | 33.34 | -25.04 | -75.83 | 12.49 | 60.27 | -16.13 | -36.57 | 3.19 | 43.53 | 8.04 |
| EPS in Rs | -0.11 | -20.98 | -0.82 | 15.44 | -11.59 | -35.11 | 5.78 | 27.90 | -7.47 | -16.93 | 1.48 | 20.15 | 3.72 |
Last Updated: March 3, 2026, 9:28 am
Below is a detailed analysis of the quarterly data for Goodricke Group Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 306.37 Cr.. The value appears strong and on an upward trend. It has increased from 216.56 Cr. (Sep 2025) to 306.37 Cr., marking an increase of 89.81 Cr..
- For Expenses, as of Dec 2025, the value is 298.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 183.78 Cr. (Sep 2025) to 298.16 Cr., marking an increase of 114.38 Cr..
- For Operating Profit, as of Dec 2025, the value is 8.21 Cr.. The value appears to be declining and may need further review. It has decreased from 32.78 Cr. (Sep 2025) to 8.21 Cr., marking a decrease of 24.57 Cr..
- For OPM %, as of Dec 2025, the value is 2.68%. The value appears to be declining and may need further review. It has decreased from 15.14% (Sep 2025) to 2.68%, marking a decrease of 12.46%.
- For Other Income, as of Dec 2025, the value is 5.60 Cr.. The value appears to be declining and may need further review. It has decreased from 13.96 Cr. (Sep 2025) to 5.60 Cr., marking a decrease of 8.36 Cr..
- For Interest, as of Dec 2025, the value is 1.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.01 Cr. (Sep 2025) to 1.70 Cr., marking a decrease of 0.31 Cr..
- For Depreciation, as of Dec 2025, the value is 4.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.63 Cr. (Sep 2025) to 4.52 Cr., marking a decrease of 0.11 Cr..
- For Profit before tax, as of Dec 2025, the value is 7.59 Cr.. The value appears to be declining and may need further review. It has decreased from 40.10 Cr. (Sep 2025) to 7.59 Cr., marking a decrease of 32.51 Cr..
- For Tax %, as of Dec 2025, the value is -5.93%. The value appears to be increasing, which may not be favorable. It has increased from -8.55% (Sep 2025) to -5.93%, marking an increase of 2.62%.
- For Net Profit, as of Dec 2025, the value is 8.04 Cr.. The value appears to be declining and may need further review. It has decreased from 43.53 Cr. (Sep 2025) to 8.04 Cr., marking a decrease of 35.49 Cr..
- For EPS in Rs, as of Dec 2025, the value is 3.72. The value appears to be declining and may need further review. It has decreased from 20.15 (Sep 2025) to 3.72, marking a decrease of 16.43.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 27, 2026, 6:20 am
| Metric | Dec 2013 | Dec 2014 | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 579 | 602 | 733 | 679 | 731 | 749 | 791 | 892 | 823 | 882 | 824 | 929 | 829 |
| Expenses | 523 | 566 | 718 | 629 | 686 | 718 | 761 | 847 | 797 | 873 | 873 | 910 | 835 |
| Operating Profit | 56 | 35 | 15 | 49 | 45 | 31 | 31 | 45 | 26 | 9 | -49 | 19 | -6 |
| OPM % | 10% | 6% | 2% | 7% | 6% | 4% | 4% | 5% | 3% | 1% | -6% | 2% | -1% |
| Other Income | 10 | 10 | 11 | 14 | 21 | 15 | 12 | 10 | 10 | 19 | 14 | 25 | 41 |
| Interest | 5 | 3 | 3 | 1 | 2 | 5 | 9 | 8 | 6 | 6 | 10 | 10 | 7 |
| Depreciation | 13 | 13 | 21 | 14 | 15 | 16 | 21 | 21 | 21 | 21 | 21 | 20 | 18 |
| Profit before tax | 49 | 29 | 3 | 49 | 49 | 26 | 13 | 26 | 9 | 3 | -66 | 14 | 9 |
| Tax % | 31% | 23% | 526% | 32% | 35% | 63% | -29% | 26% | 43% | 113% | 6% | -43% | |
| Net Profit | 33 | 22 | -12 | 33 | 32 | 9 | 16 | 20 | 5 | -0 | -69 | 20 | 18 |
| EPS in Rs | 15.44 | 10.30 | -5.62 | 15.34 | 14.69 | 4.39 | 7.56 | 9.04 | 2.44 | -0.15 | -32.08 | 9.29 | 8.42 |
| Dividend Payout % | 29% | 44% | -71% | 29% | 31% | 91% | 0% | 33% | 123% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -3.03% | -71.88% | 77.78% | 25.00% | -75.00% | -100.00% | 128.99% |
| Change in YoY Net Profit Growth (%) | 0.00% | -68.84% | 149.65% | -52.78% | -100.00% | -25.00% | 228.99% |
Goodricke Group Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 3% |
| 3 Years: | 4% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -15% |
| 3 Years: | 11% |
| TTM: | 110% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -8% |
| 3 Years: | -4% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | -7% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 3:40 pm
Balance Sheet
Last Updated: March 3, 2026, 3:04 am
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 181 | 192 | 252 | 270 | 285 | 285 | 279 | 298 | 301 | 289 | 220 | 249 | 300 |
| Borrowings | 8 | 8 | -0 | -0 | 19 | 53 | 88 | 82 | 42 | 68 | 126 | 77 | 120 |
| Other Liabilities | 150 | 175 | 195 | 190 | 236 | 239 | 231 | 262 | 272 | 261 | 281 | 294 | 265 |
| Total Liabilities | 360 | 396 | 468 | 481 | 562 | 598 | 620 | 663 | 636 | 639 | 648 | 641 | 706 |
| Fixed Assets | 98 | 100 | 209 | 217 | 250 | 300 | 315 | 313 | 316 | 317 | 326 | 307 | 288 |
| CWIP | 2 | 2 | 33 | 37 | 40 | 31 | 34 | 35 | 33 | 33 | 24 | 21 | 24 |
| Investments | -0 | -0 | -0 | 14 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 1 |
| Other Assets | 261 | 294 | 227 | 213 | 272 | 267 | 271 | 314 | 288 | 289 | 298 | 312 | 394 |
| Total Assets | 360 | 396 | 468 | 481 | 562 | 598 | 620 | 663 | 636 | 639 | 648 | 641 | 706 |
Below is a detailed analysis of the balance sheet data for Goodricke Group Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
- For Reserves, as of Sep 2025, the value is 300.00 Cr.. The value appears strong and on an upward trend. It has increased from 249.00 Cr. (Mar 2025) to 300.00 Cr., marking an increase of 51.00 Cr..
- For Borrowings, as of Sep 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 77.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 43.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 265.00 Cr.. The value appears to be improving (decreasing). It has decreased from 294.00 Cr. (Mar 2025) to 265.00 Cr., marking a decrease of 29.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 706.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 641.00 Cr. (Mar 2025) to 706.00 Cr., marking an increase of 65.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 288.00 Cr.. The value appears to be declining and may need further review. It has decreased from 307.00 Cr. (Mar 2025) to 288.00 Cr., marking a decrease of 19.00 Cr..
- For CWIP, as of Sep 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 394.00 Cr.. The value appears strong and on an upward trend. It has increased from 312.00 Cr. (Mar 2025) to 394.00 Cr., marking an increase of 82.00 Cr..
- For Total Assets, as of Sep 2025, the value is 706.00 Cr.. The value appears strong and on an upward trend. It has increased from 641.00 Cr. (Mar 2025) to 706.00 Cr., marking an increase of 65.00 Cr..
Notably, the Reserves (300.00 Cr.) exceed the Borrowings (120.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 48.00 | 27.00 | 15.00 | 49.00 | 26.00 | -22.00 | -57.00 | -37.00 | -16.00 | -59.00 | -175.00 | -58.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 56 | 18 | 16 | 37 | 26 | 25 | 24 | 23 | 27 | 32 | 29 |
| Inventory Days | 276 | 357 | 213 | 198 | 200 | 212 | 181 | 185 | 220 | 183 | 188 | 179 |
| Days Payable | 146 | 139 | 144 | 146 | 198 | 188 | 157 | 141 | 214 | 170 | 213 | 203 |
| Cash Conversion Cycle | 188 | 274 | 86 | 68 | 39 | 50 | 50 | 69 | 30 | 40 | 8 | 6 |
| Working Capital Days | 60 | 62 | 33 | 29 | 38 | 34 | 7 | 19 | 27 | 17 | -7 | 15 |
| ROCE % | 25% | 15% | 2% | 18% | 16% | 9% | 6% | 9% | 4% | 1% | -15% | 3% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 9.29 | -32.08 | -0.15 | 2.44 | 9.04 |
| Diluted EPS (Rs.) | 9.29 | -32.08 | -0.15 | 2.44 | 9.04 |
| Cash EPS (Rs.) | 18.47 | -22.51 | 9.38 | 12.28 | 18.67 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 125.25 | 111.68 | 143.93 | 149.28 | 147.84 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 125.25 | 111.68 | 143.93 | 149.28 | 147.84 |
| Dividend / Share (Rs.) | 0.00 | 0.00 | 0.00 | 3.00 | 3.00 |
| Revenue From Operations / Share (Rs.) | 430.30 | 381.47 | 408.42 | 381.07 | 412.76 |
| PBDIT / Share (Rs.) | 17.93 | -16.13 | 13.25 | 16.80 | 25.31 |
| PBIT / Share (Rs.) | 8.75 | -25.70 | 3.72 | 6.96 | 15.69 |
| PBT / Share (Rs.) | 6.50 | -30.38 | 1.17 | 4.25 | 12.14 |
| Net Profit / Share (Rs.) | 9.29 | -32.09 | -0.14 | 2.44 | 9.04 |
| PBDIT Margin (%) | 4.16 | -4.22 | 3.24 | 4.40 | 6.13 |
| PBIT Margin (%) | 2.03 | -6.73 | 0.91 | 1.82 | 3.80 |
| PBT Margin (%) | 1.51 | -7.96 | 0.28 | 1.11 | 2.94 |
| Net Profit Margin (%) | 2.15 | -8.41 | -0.03 | 0.64 | 2.19 |
| Return on Networth / Equity (%) | 7.41 | -28.72 | -0.10 | 1.63 | 6.11 |
| Return on Capital Employeed (%) | 4.83 | -15.14 | 1.88 | 3.39 | 7.83 |
| Return On Assets (%) | 3.12 | -10.69 | -0.05 | 0.82 | 2.94 |
| Long Term Debt / Equity (X) | 0.05 | 0.06 | 0.05 | 0.06 | 0.08 |
| Total Debt / Equity (X) | 0.25 | 0.47 | 0.18 | 0.09 | 0.21 |
| Asset Turnover Ratio (%) | 1.44 | 1.28 | 1.38 | 1.27 | 1.39 |
| Current Ratio (X) | 1.19 | 1.00 | 1.26 | 1.39 | 1.28 |
| Quick Ratio (X) | 0.56 | 0.49 | 0.56 | 0.51 | 0.49 |
| Inventory Turnover Ratio (X) | 6.19 | 1.48 | 1.61 | 1.38 | 1.99 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 122.84 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 24.43 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | -22.84 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 75.57 | 0.00 |
| Interest Coverage Ratio (X) | 3.81 | -3.45 | 5.20 | 6.20 | 7.13 |
| Interest Coverage Ratio (Post Tax) (X) | 2.45 | -5.86 | 0.94 | 1.90 | 3.55 |
| Enterprise Value (Cr.) | 420.77 | 450.25 | 397.36 | 451.08 | 501.19 |
| EV / Net Operating Revenue (X) | 0.45 | 0.54 | 0.45 | 0.54 | 0.56 |
| EV / EBITDA (X) | 10.86 | -12.92 | 13.88 | 12.43 | 9.17 |
| MarketCap / Net Operating Revenue (X) | 0.38 | 0.42 | 0.40 | 0.52 | 0.50 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | -22.84 | 0.00 |
| Price / BV (X) | 1.34 | 1.46 | 1.14 | 1.34 | 1.41 |
| Price / Net Operating Revenue (X) | 0.38 | 0.42 | 0.40 | 0.52 | 0.50 |
| EarningsYield | 0.05 | -0.19 | 0.00 | 0.01 | 0.04 |
After reviewing the key financial ratios for Goodricke Group Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.29. This value is within the healthy range. It has increased from -32.08 (Mar 24) to 9.29, marking an increase of 41.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.29. This value is within the healthy range. It has increased from -32.08 (Mar 24) to 9.29, marking an increase of 41.37.
- For Cash EPS (Rs.), as of Mar 25, the value is 18.47. This value is within the healthy range. It has increased from -22.51 (Mar 24) to 18.47, marking an increase of 40.98.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 125.25. It has increased from 111.68 (Mar 24) to 125.25, marking an increase of 13.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 125.25. It has increased from 111.68 (Mar 24) to 125.25, marking an increase of 13.57.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 430.30. It has increased from 381.47 (Mar 24) to 430.30, marking an increase of 48.83.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.93. This value is within the healthy range. It has increased from -16.13 (Mar 24) to 17.93, marking an increase of 34.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from -25.70 (Mar 24) to 8.75, marking an increase of 34.45.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.50. This value is within the healthy range. It has increased from -30.38 (Mar 24) to 6.50, marking an increase of 36.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.29. This value is within the healthy range. It has increased from -32.09 (Mar 24) to 9.29, marking an increase of 41.38.
- For PBDIT Margin (%), as of Mar 25, the value is 4.16. This value is below the healthy minimum of 10. It has increased from -4.22 (Mar 24) to 4.16, marking an increase of 8.38.
- For PBIT Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. It has increased from -6.73 (Mar 24) to 2.03, marking an increase of 8.76.
- For PBT Margin (%), as of Mar 25, the value is 1.51. This value is below the healthy minimum of 10. It has increased from -7.96 (Mar 24) to 1.51, marking an increase of 9.47.
- For Net Profit Margin (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 5. It has increased from -8.41 (Mar 24) to 2.15, marking an increase of 10.56.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 15. It has increased from -28.72 (Mar 24) to 7.41, marking an increase of 36.13.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.83. This value is below the healthy minimum of 10. It has increased from -15.14 (Mar 24) to 4.83, marking an increase of 19.97.
- For Return On Assets (%), as of Mar 25, the value is 3.12. This value is below the healthy minimum of 5. It has increased from -10.69 (Mar 24) to 3.12, marking an increase of 13.81.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.25, marking a decrease of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.44. It has increased from 1.28 (Mar 24) to 1.44, marking an increase of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has increased from 1.00 (Mar 24) to 1.19, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.49 (Mar 24) to 0.56, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.19. This value is within the healthy range. It has increased from 1.48 (Mar 24) to 6.19, marking an increase of 4.71.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.81. This value is within the healthy range. It has increased from -3.45 (Mar 24) to 3.81, marking an increase of 7.26.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 3. It has increased from -5.86 (Mar 24) to 2.45, marking an increase of 8.31.
- For Enterprise Value (Cr.), as of Mar 25, the value is 420.77. It has decreased from 450.25 (Mar 24) to 420.77, marking a decrease of 29.48.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.54 (Mar 24) to 0.45, marking a decrease of 0.09.
- For EV / EBITDA (X), as of Mar 25, the value is 10.86. This value is within the healthy range. It has increased from -12.92 (Mar 24) to 10.86, marking an increase of 23.78.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.38, marking a decrease of 0.04.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.34, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.38, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from -0.19 (Mar 24) to 0.05, marking an increase of 0.24.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Goodricke Group Ltd:
- Net Profit Margin: 2.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.83% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.41% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 112 (Industry average Stock P/E: 52.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.15%
About the Company - Qualitative Analysis
Goodricke Group Ltd. is a Public Limited Listed company incorporated on 14/06/1977 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L01132WB1977PLC031054 and registration number is 031054. Currently company belongs to the Industry of Tea & Coffee. Company's Total Operating Revenue is Rs. 929.44 Cr. and Equity Capital is Rs. 21.60 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Camellia House, 14, Gurusaday Road, Kolkata West Bengal 700019 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Stephen Charles Buckland | Chairman |
| Mr. Arun Narain Singh | VC & Mng.Director & CEO |
| Mr. S Mukherjee | Director - Finance & CFO |
| Mrs. Susan Ann Walker | Director |
| Mr. Sourav Adhikari | Director |
| Mr. Srikumar Menon | Director |
| Dr.(Mrs.) Rupali Basu | Director |
| Mr. Monojit Dasgupta | Director |
FAQ
What is the intrinsic value of Goodricke Group Ltd?
Goodricke Group Ltd's intrinsic value (as of 05 March 2026) is ₹498.94 which is 230.42% higher the current market price of ₹151.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹326 Cr. market cap, FY2025-2026 high/low of ₹240/149, reserves of ₹300 Cr, and liabilities of ₹706 Cr.
What is the Market Cap of Goodricke Group Ltd?
The Market Cap of Goodricke Group Ltd is 326 Cr..
What is the current Stock Price of Goodricke Group Ltd as on 05 March 2026?
The current stock price of Goodricke Group Ltd as on 05 March 2026 is ₹151.
What is the High / Low of Goodricke Group Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Goodricke Group Ltd stocks is ₹240/149.
What is the Stock P/E of Goodricke Group Ltd?
The Stock P/E of Goodricke Group Ltd is 112.
What is the Book Value of Goodricke Group Ltd?
The Book Value of Goodricke Group Ltd is 149.
What is the Dividend Yield of Goodricke Group Ltd?
The Dividend Yield of Goodricke Group Ltd is 0.00 %.
What is the ROCE of Goodricke Group Ltd?
The ROCE of Goodricke Group Ltd is 3.22 %.
What is the ROE of Goodricke Group Ltd?
The ROE of Goodricke Group Ltd is 2.86 %.
What is the Face Value of Goodricke Group Ltd?
The Face Value of Goodricke Group Ltd is 10.0.